Unicycive Therapeutics Inc (NASDAQ:UNCY) does about 380.06K shares in volume on a normal day but saw 1982099 shares change hands in Monday trading. The company now has a market cap of 42.41M USD. Its current market price is $1.22, marking an increase of 18.45% compared to the previous close of $1.03. The 52 week high reached by this stock is $1.82 whilst the lowest price level in 52 weeks is $0.47.
Unicycive Therapeutics Inc (UNCY) has a 20-day trading average at $1.2080 and the current price is -33.07% off the 52-week high compared with 159.57% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.3724 and its 200-day simple moving average is $0.9500. If we look at the stock’s price movements over the week, volatility stands at 13.11%, which decreases to 10.03% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 50.31 to suggest the stock is neutral.
The consensus objective for the share price is $5.30, suggesting that the stock has a potential upside of 76.98% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 04, 2024 when Piper Sandler initiated the stock to “Overweight” and issued a price target of $9.
Unicycive Therapeutics Inc (UNCY) stock is up 6.09% over the week and -11.59% over the past month. Its price is 40.60% year-to-date and -8.27% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of -0.97 below consensus estimates by -0.6. The company’s next earnings report forecasts estimating quarterly EPS at -0.15 and -0.49 for whole year.
To reach the target analysts have set, the stock logically needs to grow 76.98 percent from here.
The company has a return on equity of -700.45%. The beta has a value of 2.73. Price to sales ratio is 62.36.
